Controversies in the management of rare gynecologic cancers

Int J Gynecol Cancer. 2025 Mar;35(3):101677. doi: 10.1016/j.ijgc.2025.101677. Epub 2025 Jan 27.

Authors

David M Gershenson¹, Jonathan Ledermann², Isabelle Ray-Coquard³

Affiliations

¹ The University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology & Reproductive Medicine, Houston, TX, USA. Electronic address: dgershen@mdanderson.org.
² University College London, UCL Cancer Institute, UCL Cancer Trials Centre, London, United Kingdom.
³ Medical Oncology Department, Gynecology Section, Centre Léon Bérard, Lyon France.

PMID: 39983367
DOI: 10.1016/j.ijgc.2025.101677

No abstract available

Keywords: Clinical trials; Controversies; Rare gynecologic cancers.

Publication types

Editorial